LRRK2 and ubiquitination: implications for kinase inhibitor therapy.

Abstract excerpt

Pathogenic mutations and risk variants in LRRK2 (leucine-rich repeat kinase 2) represent the most common genetic cause of familial and sporadic PD (Parkinson's disease). LRRK2 protein is widely expressed throughout the brain and the periphery. Structurally, LRRK2 contains several functional domains, including a dual enzymatic core consisting of a kinase and GTPase domain. Disease-linked variants are found in both...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to 14-3-3 Proteins
• Share to Cytoplasm
• Share to Mutation